Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 100


Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK: results from the cross-sectional ASTRA study.

Daskalopoulou M, Rodger A, Phillips AN, Sherr L, Speakman A, Collins S, Elford J, Johnson MA, Gilson R, Fisher M, Wilkins E, Anderson J, McDonnell J, Edwards S, Perry N, O'Connell R, Lascar M, Jones M, Johnson AM, Hart G, Miners A, Geretti AM, Burman WJ, Lampe FC.

Lancet HIV. 2014 Oct;1(1):e22-31. doi: 10.1016/S2352-3018(14)70001-3. Epub 2014 Sep 7.


Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus.

Jenkins TC, Knepper BC, Jason Moore S, Saveli CC, Pawlowski SW, Perlman DM, McCollister BD, Burman WJ.

Acad Emerg Med. 2015 Aug;22(8):993-7. doi: 10.1111/acem.12727. Epub 2015 Jul 22.


Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship.

Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC.

Infect Control Hosp Epidemiol. 2015 Apr;36(4):474-8. doi: 10.1017/ice.2014.85.


Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use.

Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, Wilson ML, Price CS, Burman WJ, Mehler PS.

Infect Control Hosp Epidemiol. 2015 Jun;36(6):664-72. doi: 10.1017/ice.2015.41. Epub 2015 Mar 5.


Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Lifson AR, Grandits GA, Gardner EM, Wolff MJ, Pulik P, Williams I, Burman WJ; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group.

HIV Med. 2015 Apr;16 Suppl 1:88-96. doi: 10.1111/hiv.12237.


Drug-resistance mechanisms and tuberculosis drugs.

Köser CU, Javid B, Liddell K, Ellington MJ, Feuerriegel S, Niemann S, Brown NM, Burman WJ, Abubakar I, Ismail NA, Moore D, Peacock SJ, Török ME.

Lancet. 2015 Jan 24;385(9965):305-7. doi: 10.1016/S0140-6736(14)62450-8. No abstract available.


Comparison of the microbiology and antibiotic treatment among diabetic and nondiabetic patients hospitalized for cellulitis or cutaneous abscess.

Jenkins TC, Knepper BC, Jason Moore S, Saveli CC, Pawlowski SW, Perlman DM, McCollister BD, Burman WJ.

J Hosp Med. 2014 Dec;9(12):788-94. doi: 10.1002/jhm.2267. Epub 2014 Sep 30.


Clinical characteristics and antibiotic utilization in pediatric patients hospitalized with acute bacterial skin and skin structure infection.

Moore SJ, O'Leary ST, Caldwell B, Knepper BC, Pawlowski SW, Burman WJ, Jenkins TC.

Pediatr Infect Dis J. 2014 Aug;33(8):825-8. doi: 10.1097/INF.0000000000000304.


Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.

Jenkins TC, Knepper BC, Moore SJ, O'Leary ST, Brooke Caldwell, Saveli CC, Pawlowski SW, Perlman DM, McCollister BD, Burman WJ.

Infect Control Hosp Epidemiol. 2014 Oct;35(10):1241-50. doi: 10.1086/678056. Epub 2014 Aug 20.


Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city.

Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM.

AIDS Patient Care STDS. 2014 Sep;28(9):475-82. doi: 10.1089/apc.2013.0340. Epub 2014 Aug 1.


Rifapentine Pharmacokinetics and Tolerability in Children and Adults Treated Once Weekly With Rifapentine and Isoniazid for Latent Tuberculosis Infection.

Weiner M, Savic RM, Kenzie WR, Wing D, Peloquin CA, Engle M, Bliven E, Prihoda TJ, Gelfond JA, Scott NA, Abdel-Rahman SM, Kearns GL, Burman WJ, Sterling TR, Villarino ME; Tuberculosis Trials Consortium PREVENT TB Pharmacokinetic Group.

J Pediatric Infect Dis Soc. 2014 Jun;3(2):132-45. doi: 10.1093/jpids/pit077. Epub 2014 Jan 16.


Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting.

Hurley HJ, Knepper BC, Price CS, Mehler PS, Burman WJ, Jenkins TC.

Am J Med. 2013 Dec;126(12):1099-106. doi: 10.1016/j.amjmed.2013.08.016.


The 'Antiretrovirals, Sexual Transmission Risk and Attitudes' (ASTRA) study. Design, methods and participant characteristics.

Speakman A, Rodger A, Phillips AN, Gilson R, Johnson M, Fisher M, Ed Wilkins, Anderson J, O'Connell R, Lascar M, Aderogba K, Edwards S, McDonnell J, Perry N, Sherr L, Collins S, Hart G, Johnson AM, Miners A, Elford J, Geretti AM, Burman WJ, Lampe FC.

PLoS One. 2013 Oct 15;8(10):e77230. doi: 10.1371/journal.pone.0077230. eCollection 2013.


Initial linkage and subsequent retention in HIV care for a newly diagnosed HIV-infected cohort in Denver, Colorado.

Gardner EM, Daniloff E, Thrun MW, Reirden DH, Davidson AJ, Johnson SC, Wilmoth R, Connick E, Burman WJ.

J Int Assoc Provid AIDS Care. 2013 Nov-Dec;12(6):384-90. doi: 10.1177/2325957413500532. Epub 2013 Aug 20.


Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.

Das R, Koo MS, Kim BH, Jacob ST, Subbian S, Yao J, Leng L, Levy R, Murchison C, Burman WJ, Moore CC, Scheld WM, David JR, Kaplan G, MacMicking JD, Bucala R.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2997-3006. doi: 10.1073/pnas.1301128110. Epub 2013 Jul 23.


Requirements for the clinical evaluation of new anti-tuberculosis agents in children.

Donald PR, Ahmed A, Burman WJ, Cotton MF, Graham SM, Mendel C, McIlleron H, Mac Kenzie WR, Nachman S, Schaaf HS, Starke JR, Wingfield C, Hesseling AC.

Int J Tuberc Lung Dis. 2013 Jun;17(6):794-9. doi: 10.5588/ijtld.12.0567.


The association between symptoms and microbiologically defined response to tuberculosis treatment.

Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ.

Ann Am Thorac Soc. 2013 Feb;10(1):18-25. doi: 10.1513/AnnalsATS.201207-038OC.


Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.

Jenkins TC, Stella SA, Cervantes L, Knepper BC, Sabel AL, Price CS, Shockley L, Hanley ME, Mehler PS, Burman WJ.

Infection. 2013 Feb;41(1):135-44. doi: 10.1007/s15010-012-0362-2. Epub 2012 Nov 17.


Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.

Jenkins TC, Sakai J, Knepper BC, Swartwood CJ, Haukoos JS, Long JA, Price CS, Burman WJ.

Acad Emerg Med. 2012 Jun;19(6):703-6. doi: 10.1111/j.1553-2712.2012.01365.x. Epub 2012 May 25.


Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.

Dooley KE, Bliven-Sizemore EE, Weiner M, Lu Y, Nuermberger EL, Hubbard WC, Fuchs EJ, Melia MT, Burman WJ, Dorman SE.

Clin Pharmacol Ther. 2012 May;91(5):881-8. doi: 10.1038/clpt.2011.323.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk